发明授权
- 专利标题： Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
- 专利标题（中）： 与具有I型或II型核心结构的血型决定簇相关的寡糖糖苷的时间依赖性施用可减少敏感性哺乳动物中暴露于抗原的炎症
-
申请号： US405785申请日： 1995-03-17
-
公开(公告)号： US5646123A公开(公告)日： 1997-07-08
- 发明人: Robert M. Ippolito , Wasimul Haque , Cong Jiang , H. Rizk Hanna , Andre P. Venot , Pandurang V. Nikrad , Mohammed A. Kashem , Richard Smith , Om P. Srivastava
- 申请人： Robert M. Ippolito , Wasimul Haque , Cong Jiang , H. Rizk Hanna , Andre P. Venot , Pandurang V. Nikrad , Mohammed A. Kashem , Richard Smith , Om P. Srivastava
- 申请人地址： CAX Alberta
- 专利权人： Alberta Research Council
- 当前专利权人： Alberta Research Council
- 当前专利权人地址： CAX Alberta
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; C07H3/06 ; C07H15/04 ; C07H19/10 ; C07H19/20 ; A61K31/70 ; C07H15/00
摘要：
Disclosed are methods for reducing the degree of antigen induced inflammation in a sensitized mammals. The disclosed methods employ oligosaccharide glycosides related to blood group determinants having a type I or type II core structure wherein the administration of such oligosaccharide glycosides is after initiation of the mammal's immune response but at or prior one-half the period of time required to effect maximal antigen-induced inflammation.
公开/授权文献
- US5020887A Conformally doped optical elements 公开/授权日：1991-06-04
信息查询
